More: AIDS 2008: XVII International AIDS Conference

AIDS 2008: HIV Coinfections and Comorbidities CME/CE

August 3 - 8, 2008, Mexico City, Mexico

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the International AIDS Conference. Conference news does not receive grant support and is produced independently.

Release Date: September 26, 2008; Valid for credit through September 26, 2009

Credits Available
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 0.75 ANCC contact hours (0.5 contact hours are in the area of pharmacology )

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the International AIDS Conference. These materials and the related activity are not sanctioned by the International AIDS Conference or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review current epidemiology and management of HIV and hepatitis
  2. Describe data presented at IAC regarding antiretroviral therapy adverse events
Authors and Disclosures

Vincent V. Soriano, MD, PhD
Disclosure: Vincent V. Soriano, MD, PhD, has disclosed that he has received grants for clinical research and educational activities from, and has served as an advisor or consultant to, Schering-Plough, Roche, Bristol-Myers Squibb, and Gilead.


Paul E. Sax, MD
Disclosure: Paul E. Sax, MD, has disclosed that he has received grant support from Bristol-Myers Squibb, Merck, and Pfizer, and has served as an advisor or consultant to Abbott, Bristol-Myers Squibb, Gilead, and GlaxoSmithKline. Dr. Sax has also disclosed that he has received honoraria for teaching from Abbott, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Tibotec, and Virco.


Laurie E. Scudder, MS, NP-C
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant financial relationships.


Thomas Maxwell Mundy, MD
Disclosure: Thomas Maxwell Mundy, MD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.